The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: Systematic review

Cost Effectiveness and Resource Allocation

Volumn 9, Issue , 2011, Pages

  Johri, Mira ^a,b   Ako Arrey, Denis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA SOUTH OF THE SAHARA; BIBLIOGRAPHIC DATABASE; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; DATA SYNTHESIS; ECONOMIC EVALUATION; EMBASE; EPIDEMIC; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MEDLINE; PREGNANT WOMAN; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 79651474589     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-9-3     Document Type: Review

References (54)

1. 2009 Report on the global AIDS epidemic. , http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp
2. UNAIDS Report on the global AIDS epidemic 2010. , http://www.unaids.org/globalreport/default.htm
3. World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings 2004, Geneva: World Health Organization, World Health Organization.
4. De Cock KM, Fowler MG, Mercier E, de VI, Saba J, Hoff E, Alnwick DJ, Rogers M, Shaffer N. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA: The Journal of the American Medical Association 2000, 283:1175-1182. 10.1001/jama.283.9.1175, 10703780.
5. WHO HIV and Infant Feeding Technical Consultation Consensus Statement Held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV Infections in Pregnant Women, Mothers and their Infants. , http://www.who.int/child_adolescent_health/documents/9789241599535/en/index.html
6. Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS. Interventions for preventing late postnatal mother-to-child transmission of HIV. CochraneDatabaseSystRev 2009, CD006734.
7. Read JS, Newell MK. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. CochraneDatabaseSystRev 2005, CD005479.
8. Wiysonge CS, Shey MS, Sterne JA, Brocklehurst P. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection. CochraneDatabaseSystRev 2005, CD003648.
9. Wiysonge CS, Shey MS, Shang JD, Sterne JA, Brocklehurst P. Vaginal disinfection for preventing mother-to-child transmission of HIV infection. CochraneDatabaseSystRev 2005, CD003651.
10. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. CochraneDatabaseSystRev 2007, CD003510.
11. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. CochraneDatabaseSystRev 2002, CD003510.
12. World Health Organization PMTCT strategic vision 2010-2015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals 2010, Geneva: World Health Organization, World Health Organization.
13. World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. - 2010 version 2010, Geneva: World Health Organization, World Health Organization.
14. World Health Organization Guidelines on HIV and infant feeding. 2010. Principles and recommendations for infant feeding in the context of HIV and a summary of evidence 2010, Geneva: World Health Organization, World Health Organization.
15. Endnote X2. 2008, Thompson Reuters.
16. 2008 Country ClassificationTables. , http://go.worldbank.org/K2CKM78CC0
17. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 2005, New York: Oxford University Press.
18. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996, 313:275-283. 2351717, 8704542.
19. Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. JAMA 2002, 287:2809-2812. 10.1001/jama.287.21.2809, 12038919.
20. Gerard K, Seymour J, Smoker I. A tool to improve quality of reporting published economic analyses. Int J Technol Assess Health Care 2000, 16:100-110. 10.1017/S0266462300016196, 10815357.
21. Pegurri E, Fox-Rushby JA, Damian W. The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review. Vaccine 2005, 23:1624-1635. 10.1016/j.vaccine.2004.02.029, 15694515.
22. Kumar M, Birch S, Maturana A, Gafni A. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India. Health Policy 2006, 77:233-243. 10.1016/j.healthpol.2005.07.014, 16126300.
23. Rely K, Bertozzi SM, Avila-Figueroa C, Guijarro MT. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting. Health Policy and Planning 2003, 18:290-298. 10.1093/heapol/czg035, 12917270.
24. Reynolds HW, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006, 33:350-356. 10.1097/01.olq.0000194602.01058.e1, 16505747.
25. Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 2004, 18:1661-1671. 10.1097/01.aids.0000131353.06784.8f, 15280777.
26. Halperin DT, Stover J, Reynolds HW. Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS 2009, 23(Suppl 1):S123-130. 10.1097/01.aids.0000363785.73450.5a, 20081384.
27. John FN, Farquhar C, Kiarie JN, Kabura MN, John-Stewart GC. Cost effectiveness of couple counselling to enhance infant HIV-1 prevention. Int J STD AIDS 2008, 19:406-409. 2765914, 18595879.
28. Teerawattananon Y, Vos T, Tangcharoensathien V, Mugford M. Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen. Cost Eff Resour Alloc 2005, 3:7. 10.1186/1478-7547-3-7, 1181823, 16026626.
29. Soorapanth S, Sansom S, Bulterys M, Besser M, Theron G, Fowler MG. Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings. Journal of Acquired Immune Deficiency Syndromes: JAIDS42 2006, (2):213-21.
30. Wilkinson D, Floyd K, Gilks CF. Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. AIDS 1998, 12:1675-1682. 10.1097/00002030-199813000-00016, 9764788.
31. Soderlund N, Zwi K, Kinghorn A, Gray G. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ 1999, 318:1650-1656. 28142, 10373166.
32. Maclean CC, Stringer JS. Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding. J Acquir Immune Defic Syndr 2005, 38:570-577. 10.1097/01.qai.0000142919.51570.88, 15793368.
33. Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting. JAMA 1996, 276:139-145. 10.1001/jama.276.2.139, 8656506.
34. Marseille E, Kahn JG, Saba J. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS 1998, 12:939-948. 10.1097/00002030-199808000-00017, 9631148.
35. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 1999, 354:803-809.
36. Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr 2000, 24:369-377.
37. Wilkinson D, Floyd K, Gilks CF. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa. S Afr Med J 2000, 90:794-798.
38. Wood E, Braitstein P, Montaner JS, Schechter MT, Tyndall MW, O'Shaughnessy MV, Hogg RS. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet 2000, 355:2095-2100. 10.1016/S0140-6736(00)02375-8, 10902622.
39. Orlando S, Marazzi MC, Mancinelli S, Liotta G, Ceffa S, Giglio P, Alumando E, Ziegler I, Shawa M, Palombi L. Cost-effectiveness of Using HAART in Prevention of Mother-to-Child Transmission in the DREAM-Project Malawi. J Acquir Immune Defic Syndr 2010, 55:631-634.
40. Robberstad B, Evjen-Olsen B. Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania--a prospective cost-effectiveness study. J Acquir Immune Defic Syndr 2010, 55:397-403. 10.1097/QAI.0b013e3181eef4d3, 20739897.
41. Scotland GS, van Teijlingen ER, van der Pol M, Smith WC. A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS 2003, 17:1045-1052. 10.1097/00002030-200305020-00014, 12700455.
42. Johns B, Baltussen R, Hutubessy R. Programme costs in the economic evaluation of health interventions. Cost Eff Resour Alloc 2003, 1:1. 10.1186/1478-7547-1-1, 156020, 12773220.
43. International Bank for Reconstruction and Development/The World Bank World Development Report 1993: Investing in Health. World Development Report 1993: Investing in Health 1993, Oxford University Press, International Bank for Reconstruction and Development/The World Bank.
44. World Health Organization Macroeconomics and Health: Investing in Health for Economic Development. Macroeconomics and Health: Investing in Health for Economic Development 2001, 1-200. World Health Organisation, World Health Organization.
45. Brisson M, Edmunds WJ. Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs. Med Decis Making 2006, 26:434-446. 10.1177/0272989X06290485, 16997923.
46. Adam T, Evans DB, Murray CJ. Econometric estimation of country-specific hospital costs. Cost Eff Resour Alloc 2003, 1:3. 10.1186/1478-7547-1-3, 156022, 12773218.
47. Ainsworth M, Teokul W. Breaking the silence: setting realistic priorities for AIDS control in less-developed countries. Lancet 2000, 356:55-60. 10.1016/S0140-6736(00)02440-5, 10892777.
48. Tan-Torres Edeger T, Baltussen R, Adam T, Aikins M, Hutubessy RC, Acharya A, Evans DB, Murray CJL. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis 2003, 1-250. Geneva: World Health Organization.
49. Baltussen R, Stolk E, Chisholm D, Aikins M. Towards a multi-criteria approach for priority setting: an application to Ghana. Health Econ 2006, 15:689-696. 10.1002/hec.1092, 16491464.
50. World Health Organization Priority interventions: HIV/AIDS prevention, treatment and care in the health sector 2009, Geneva: World Health Organization, World Health Organization.
51. UNGASS Declaration of Commitment on HIV/AIDS. UNGASS Declaration of Commitment on HIV/AIDS 2001,
52. World Health Organization Regional Office for the Western Pacific, United Nations Children's Fund Workshop on Expanding Linkages between HIV/STI services with Reproductive, Adolescent, Maternal, Newborn and Child Health Services: Meeting Report. Workshop on Expanding Linkages between HIV/STI services with Reproductive, Adolescent, Maternal, Newborn and Child Health Services: Meeting Report 2009, World Health Organization Regional Office for the Western Pacific, United Nations Children's Fund.
53. Church K, Mayhew SH. Integration of STI and HIV prevention, care, and treatment into family planning services: a review of the literature. Stud Fam Plann 2009, 40:171-186. 10.1111/j.1728-4465.2009.00201.x, 19852408.
54. World Economic Outlook. , http://www.imf.org/external/pubs/ft/weo/2009/01/weodata/weoselgr.aspx